Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Notes Payables (2010 - 2026)

Updated

Brainstorm Cell Therapeutics' Notes Payables came in at $1.26 million for Q2 2026, compared with $101,000 a year earlier and down 5.1% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Notes Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, Brainstorm Cell Therapeutics' Notes Payables was $967,000, up 222.3% from FY2024.

  • Going back by year, Notes Payables was $300,000 in FY2024.
  • The five-year range for quarterly Notes Payables is $101,000 (Q2 2025) to $1.33 million (Q1 2026).
  • Business Quant data shows BCLI's Notes Payables at $1.33 million (Q1 2026), $967,000 (Q4 2025) and $101,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Mn
Mar 31, 2026 1.33 Mn
Dec 31, 2025 967,000.00
Sep 30, 2025 101,000.00
Jun 30, 2025 101,000.00
Mar 31, 2025 1.20 Mn
Dec 31, 2024 300,000.00
Dec 31, 2010 137,000.00
API Access

Brainstorm Cell Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BCLI&period=max&api_key=YOUR_API_KEY